OUTCOME OF PREGNANCY WITH SARS-CoV-2 INFECTION IN LABOR AT TU DU HOSPITAL

Kim Thiện Uyên Dương1, Lâm Thương Bùi1, Minh Tuấn Võ 1,, Diễm Phượng Trương2, Hữu Thịnh Cao3
1 UMP
2 Tu Du hospital
3 An Sinh Hospital

Main Article Content

Abstract

Background: The emergence of the new virus Coronavirus 2(SARS-CoV-2) in december 2019-the COVID-19 pandemic, marked a major pandemic for the whole world. Pregnant women are at increased risk for adverse outcome related to COVID-19. This helps in timely and appropriate assessment, monitoring and intervention. Objective: Describe the characteristics of prenant women infected with SARS-CoV-2 during labor, Analysis of prenancy outcomes with SARS-CoV-2 infection in maternal and fetal labor. Methods: Retrospective case series report of all pregnant women who tested positive for SARS-CoV-2 just before labor at Tu Du hospital, from December 1, 2021 to June 30, 2022. Results: The level of mild/asymptomatic SARS-CoV-2 infection accounted for 96.33%. Common symptoms include: fever (8%), cough (8.67%), sore throat (9%). 59.33% in spontaneous labor, 17.67% induction of labor, During labor monitoring, 47.33% of cases were indicated for cesarean section, 52.67% vaginal delivery. Overall adverse outcome of mother and/or child accounted for 15.6% (95% CL: 11.57 to 19.77). In which, adverse pregnancy outcome in mothers accounted for 4% (95% CL: 1.8 to 6.2) and adverse outcomes in children accounted for 12.33% (95% CL: 8.63 to 16.03). With the rate of postpartum hemorrhage (2%), postpartum infection (2%), preterm birth (9%), low birth weight (5.33%), 1-minute Apgar <7 points (6%). Conclusions: The pregnancy outcome with SARS-CoV-2 infection accounts for 15.6%, during labor monitoring, it is necessary to closely monitor and intervene appropriately on pregnants infected with SARS-CoV-2 to limit adverse outcomes for the fetus.

Article Details

References

1. Phạm Thanh Hải, Lê Hồng Cẩm (2010), “Yếu tố nguy cơ băng huyết sau sinh”. Tạp chí Y học Thành Phố Hồ Chí Minh. 14(2), tr 36-42.
2. M. Abedzadeh-Kalahroudi, M. Sehat, Z. Vahedpour, et al. (2021), "Maternal and neonatal outcomes of pregnant patients with COVID-19: A prospective cohort study", Int J Gynaecol Obstet, 153(3), pp. 449-456.
3. R. da Rosa Mesquita, L. C. Francelino Silva Junior, F. M. Santos Santana, et al. (2021), "Clinical manifestations of COVID-19 in the general population: systematic review", Wien Klin Wochenschr, 133(7-8), pp. 377-382.
4. G. Grgić, A. Cerovac, I. Hudić, et al. (2022), "Clinical Manifestation and Obstetric Outcomes in Pregnant Women with SARS-CoV-2 Infection at Delivery: A Retrospective Cohort Analysis", J Pers Med, 12(9).
5. T. A. Manuck, M. M. Rice, J. L. Bailit, et al. (2016), "Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort", Am J Obstet Gynecol, 215(1), pp. 103.e101-103.e114.
6. M. Prabhu, K. Cagino, K. C. Matthews, et al. (2020), "Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study", Bjog, 127(12), pp. 1548-1556.
7. F. Zhou, T. Yu, R. Du, et al. (2020), "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", Lancet, 395(10229), pp. 1054-1062.
8. Tessa M. Wardlaw, Ann Klimas Blanc, Jelka Zupan, et al. (2004). Low birthweight: country regional and global estimates.